APR-246
APR-246-01
Phase 1 small_molecule completed
Quick answer
APR-246 for Hematologic Neoplasms is a Phase 1 program (small_molecule) at Aprea Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aprea Therapeutics
- Indication
- Hematologic Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed